You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 11, March 20, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
 Article Links
 •Return to Article

Downloading the PowerPoint slide may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.
Copyright restrictions may apply. Please see our Conditions of Use.



Figure. Perioperative {beta}-Blockers: Patient Selection and Preoperative Risk Stratification

Revised Cardiac Risk Index criteria5 and minor clinical criteria adapted from Mangano et al42 are listed in Table 2. Revised Cardiac Risk Index criteria exclude patients with congestive heart failure because the safety and efficacy of perioperative {beta}-blockers has not been proven in these patients. Cardiac event rates with and without {beta}-blockade are ranges based on rates from Lee et al5 for cardiovascular complications observed in the validation set (those in the derivation set were somewhat lower) and on estimates from Boersma et al.60 Options for noninvasive testing for further risk stratification include dipyramidole thallium scintigraphy, stress echocardiography, exercise electrocardiography, or cardiac catheterization in appropriate patients. Examples of activities that expend about 4 METS (metabolic equivalent tasks) include climbing 1 flight of stairs, being able to walk on level ground at 4 mph, or being able to climb a short hill without difficulty.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.